Issue 006 | U.S. Pilot | US

LAB

STANDARD BIOTOOLS INC.

Screen state: Passing Source state: Verified 10-Q | 2026-05-06 Filing currency: USD
Internal NCAV Discount 37.5%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
521,453,000USD
Total Liabilities
77,991,000USD
NCAV
443,462,000USD
Cash
265,772,000USD
NCAV per share
1.14USD/share
Evidence
10 annual | 20 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
2
Unavailable
7
Requires inspection Negative OCF -46,597,000
Latest
-46,597,0002026-03-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-208967

Supporting observation Current Ratio > 1.5 12.36
Latest
12.362026-03-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-208967

7 unavailable checks — inspect missing inputs
High Debt (short-term debt + long-term debt) / ordinary equity >= 50%
Low Debt (short-term debt + long-term debt) / ordinary equity < 20%
Material 1Y Share Increase 1Y share change >= +2% using the same share-count source
NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source
Non-Positive Equity ordinary shareholders equity <= 0
Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: no_split_evidence_reported_equals_adjusted | quality: verified

Display basis

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
2020-12-31
10-K
USD
2019-12-31
10-K
USD
2018-12-31
10-K
USD
2017-12-31
10-K
USD
2016-12-31
10-K
USD
Revenue 85,331,000 174,432,000 106,340,000 97,948,000 130,581,000 138,144,000 117,243,000 112,964,000 101,937,000 104,446,000
Operating Income -110,249,000 -175,236,000 -76,600,000 -116,205,000 -67,459,000 -51,036,000 -51,839,000 -48,164,000 -58,360,000 -73,190,000
Net Income -74,896,000 -138,885,000 -74,656,000 -190,098,000 -59,237,000 -53,020,000 -64,790,000 -59,013,000 -60,535,000 -75,985,000
Cash From Operations -74,343,000 -143,454,000 -43,287,000 -89,370,000 -44,061,000 -15,417,000 -35,210,000 -25,201,000 -24,098,000 -39,098,000
Capex -8,303,000 -8,355,000 -2,831,000 -3,825,000 -13,264,000 -12,717,000 -2,531,000 -372,000 -1,566,000 -5,065,000
Free Cash Flow -82,646,000 -151,809,000 -46,118,000 -93,195,000 -57,325,000 -28,134,000 -37,741,000 -25,573,000 -25,664,000 -44,163,000
Cash And Equivalents 120,863,000 166,728,000 51,704,000 81,309,000 28,451,000 68,520,000 21,661,000 95,401,000 58,056,000 35,045,000
Accounts Receivable 13,431,000 33,608,000 19,660,000 17,280,000 18,320,000 25,423,000 18,981,000 16,651,000 15,049,000 14,610,000
Inventory 19,981,000 40,737,000 20,533,000 21,473,000 20,825,000 19,689,000 13,884,000 13,003,000 15,088,000 20,114,000
Total Current Assets 454,264,000 375,880,000 158,215,000 208,815,000 72,066,000 117,663,000 96,096,000 127,106,000 94,801,000 96,671,000
Total Assets 567,754,000 612,344,000 323,067,000 390,310,000 275,214,000 324,757,000 264,812,000 303,647,000 287,351,000 306,395,000
Total Current Liabilities 108,308,000 65,894,000 109,327,000 43,443,000 49,568,000 54,249,000 32,821,000 37,582,000 33,474,000 29,500,000
Total Liabilities 143,463,000 140,622,000 159,865,000 160,524,000 180,618,000 185,707,000 111,200,000 231,531,000 256,416,000 253,162,000
Shareholders Equity 424,291,000 471,722,000 -148,051,000 -81,467,000 94,596,000 139,050,000 153,612,000 72,116,000 30,935,000 53,233,000
Shares Outstanding 386,381,000 377,530,000 80,232,000 79,482,000 76,919,000 74,543,000 69,956,000 49,338,000 38,787,000 29,208,000
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 381,623,000 353,245,000 79,160,000 78,305,000 75,786,000 72,044,000 66,779,000 39,652,000 32,980,000 29,008,000
Weighted Avg Shares Basic 381,623,000 353,245,000 79,160,000 78,305,000 75,786,000 72,044,000 66,779,000 39,652,000 32,980,000 29,008,000
Net Share Count Change (Normalized) Insufficient evidence -4.9% Insufficient evidence 2.6% 0.6% 6.6% 41.8% 27.2% 32.8% Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence 5.2% Insufficient evidence -2.6% -0.6% -6.2% -29.5% -21.4% -24.7% Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue 21,146,000 3,222,000 19,552,000 21,762,000 40,795,000 46,718,000 44,969,000 37,205,000 45,540,000 28,188,000 25,367,000 27,666,000 25,119,000 27,021,000 25,646,000 18,777,000 26,504,000 38,265,000 28,504,000 31,018,000
Operating Income -12,496,000 -18,644,000 -32,938,000 -25,697,000 -32,970,000 -32,817,000 -31,718,000 -50,519,000 -60,182,000 -21,386,000 -21,172,000 -17,449,000 -16,593,000 -21,112,000 -29,027,000 -38,563,000 -27,503,000 -11,259,000 -19,612,000 -17,268,000
Net Income 127,068,000 19,283,000 -34,687,000 -33,459,000 -26,033,000 -34,072,000 -26,938,000 -45,718,000 -32,157,000 -19,776,000 -20,997,000 -17,040,000 -16,843,000 -20,845,000 -29,426,000 -63,539,000 -76,288,000 -9,430,000 -13,843,000 -17,143,000
Cash From Operations -46,597,000 -1,190,000 -22,202,000 -20,668,000 -30,283,000 -14,059,000 -27,869,000 -39,050,000 -62,476,000 -14,061,000 -11,412,000 -9,329,000 -8,485,000 -19,181,000 -24,611,000 -29,988,000 -15,590,000 -7,002,000 -9,494,000 -14,664,000
Capex -570,000 -476,000 -886,000 -1,887,000 -5,054,000 -3,382,000 -2,255,000 -1,937,000 -781,000 -78,000 -905,000 -838,000 -1,010,000 -755,000 -1,264,000 -938,000 -868,000 -463,000 -1,706,000 -4,172,000
Free Cash Flow -47,167,000 -1,666,000 -23,088,000 -22,555,000 -35,337,000 -17,441,000 -30,124,000 -40,987,000 -63,257,000 -14,139,000 -12,317,000 -10,167,000 -9,495,000 -19,936,000 -25,875,000 -30,926,000 -16,458,000 -7,465,000 -11,200,000 -18,836,000
Cash And Equivalents 265,772,000 120,863,000 129,418,000 158,617,000 150,880,000 166,728,000 210,647,000 269,811,000 287,057,000 51,704,000 79,655,000 142,304,000 113,663,000 81,309,000 60,200,000 74,361,000 29,983,000 28,451,000 29,309,000 30,863,000
Total Current Assets 521,453,000 454,264,000 472,439,000 506,037,000 344,019,000 375,880,000 453,607,000 480,029,000 547,565,000 158,215,000 170,741,000 183,070,000 194,928,000 208,815,000 229,017,000 250,877,000 73,197,000 72,066,000 73,465,000 78,206,000
Total Liabilities 77,991,000 143,463,000 139,977,000 132,430,000 125,002,000 140,622,000 192,206,000 198,471,000 200,351,000 159,865,000 159,752,000 157,961,000 157,554,000 160,524,000 166,409,000 167,323,000 249,825,000 180,618,000 182,851,000 179,865,000
Shares Outstanding 390,141,000 386,381,000 383,614,000 381,691,000 379,087,000 377,530,000 372,261,000 371,123,000 380,400,000 80,232,000 79,470,000 79,121,000 78,652,000 79,482,000 79,246,000 78,654,000 77,199,000 76,919,000 76,485,000 76,166,000
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 388,202,000 385,049,967 382,630,000 380,498,000 378,228,000 374,550,848 371,538,000 372,331,000 294,125,000 79,731,924 79,152,000 78,669,000 79,080,000 79,438,043 78,897,000 77,821,000 77,031,000 76,656,913 76,301,000 75,452,000
Weighted Avg Shares Basic 388,202,000 385,049,967 382,630,000 380,498,000 378,228,000 374,550,848 371,538,000 372,331,000 294,125,000 79,731,924 79,152,000 78,669,000 79,080,000 79,438,043 78,897,000 77,821,000 77,031,000 76,656,913 76,301,000 75,452,000
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence -0.2% 26.6% -16.7% -4.9% 371.1% -73.2% Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence 2.6% 0.8% 1.9% 0.4% 0.6% 0.4% 2.2%
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence 0.2% -21.0% 20.1% 5.2% -78.8% 272.9% Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence -2.6% -0.7% -1.8% -0.4% -0.6% -0.4% -2.1%
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 521,453,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Total Liabilities 77,991,000USD us-gaap:Liabilities 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Cash 265,772,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Shares Outstanding 390,141,000 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
NCAV 443,462,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 1.14USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 37.5% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001162194
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001162194/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
26
Imported At
2026-08-15T12:52:21+00:00
Rendered At
2026-08-16T03:30:06+00:00

Run Audit

Mary Run
63eb9cbe01c34796bb5a9e8d156e6111
Mary As Of
2026-08-15
Accession
0001193125-26-208967
CIK
0001162194
Mary Filing Date
2026-05-06
Filing Currency
USD
Internal Discount
37.5%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=63eb9cbe01c34796bb5a9e8d156e6111; mary_as_of=2026-08-15; mary_filing_date=2026-05-06; mary_accession=0001193125-26-208967; mary_cik=0001162194; gnni_supporting_filing_date=2026-05-06; internal_discount=0.375369; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive